Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

333
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
333
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

688
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
688
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

883
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
883
Biopharmaceutical Factors Influencing Drug Product Design: Overview01:22

Biopharmaceutical Factors Influencing Drug Product Design: Overview

397
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
397
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

2.7K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunology Update: Long-Term Care of Solid Organ Transplant Recipients.

FP essentials·2016
Same author

Immunology Update: New Vaccines.

FP essentials·2016
Same author

Immunology Update: Primary Immunodeficiency Diseases.

FP essentials·2016
Same author

Cirrhosis: diagnosis, management, and prevention.

American family physician·2012
Same journal

Skin Cancer: Management of Cutaneous Melanoma.

FP essentials·2026
Same journal

Skin Cancer: Management of Actinic Keratoses and Keratinocyte Carcinomas.

FP essentials·2026
Same journal

Skin Cancer: Diagnosis.

FP essentials·2026
Same journal

Skin Cancer: Screening and Prevention.

FP essentials·2026
Same journal

Obesity Management: Surgical Interventions.

FP essentials·2026
Same journal

Obesity Management: Pharmacotherapy.

FP essentials·2026
See all related articles

Related Experiment Video

Updated: Mar 11, 2026

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
06:26

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Published on: January 24, 2025

2.0K

Immunology Update: Biologics.

S Paul Starr1

  • 1Department of Family Medicine Louisiana State University School of Medicine, 1542 Tulane Ave, New Orleans, LA 70112.

FP Essentials
|November 22, 2016
PubMed
Summary
This summary is machine-generated.

Biologics, derived from living organisms, are crucial treatments for various cancers and autoimmune diseases. Advanced therapies like monoclonal antibodies and PCSK9 inhibitors offer improved patient outcomes and manage complex conditions effectively.

More Related Videos

Laboratory Scale Production and Purification of a Therapeutic Antibody
09:54

Laboratory Scale Production and Purification of a Therapeutic Antibody

Published on: January 24, 2017

18.5K
Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye
06:10

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye

Published on: March 30, 2020

8.4K

Related Experiment Videos

Last Updated: Mar 11, 2026

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
06:26

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Published on: January 24, 2025

2.0K
Laboratory Scale Production and Purification of a Therapeutic Antibody
09:54

Laboratory Scale Production and Purification of a Therapeutic Antibody

Published on: January 24, 2017

18.5K
Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye
06:10

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye

Published on: March 30, 2020

8.4K

Area of Science:

  • Biotechnology and Pharmaceutical Sciences
  • Molecular Biology
  • Immunology

Background:

  • Biologics are complex therapeutic substances derived from living organisms or their components.
  • Production often involves advanced recombinant DNA technology, including monoclonal antibody and fusion protein generation.
  • These therapies are integral to modern medicine, addressing a wide spectrum of diseases.

Purpose of the Study:

  • To provide an overview of biologics, their production methods, and diverse clinical applications.
  • To highlight the significance of biologics in treating oncological and autoimmune conditions.
  • To discuss emerging biologic therapies for cardiovascular risk management.

Main Methods:

  • Review of biologics, encompassing proteins like antibodies, enzymes, and inhibitors.
  • Explanation of recombinant DNA technology for producing biologics, including chimeric monoclonal antibodies.
  • Description of clinical uses across oncology, autoimmune disorders, and cardiovascular disease prevention.

Main Results:

  • Biologics are effective in treating human epidermal growth factor receptor 2 (ERBB2)-positive breast cancer, leukemias, lymphomas, and other cancers.
  • Significant improvements in patient outcomes are observed in autoimmune disorders such as rheumatoid arthritis, psoriasis, and multiple sclerosis.
  • Biologics like erythropoietin and PCSK9 inhibitors address anemia and hyperlipidemia, respectively, demonstrating broad therapeutic utility.

Conclusions:

  • Biologics represent a vital class of therapeutics with broad applications in managing serious health conditions.
  • The continuous advancement in biologic production and application promises further improvements in patient care.
  • Biologics are essential for targeted cancer therapy, autoimmune disease management, and cardiovascular risk reduction.